Sanjiv Patel - Jul 9, 2025 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
President and CEO, Director
Signature
/s/ Brian Adams, as Attorney-in-Fact
Stock symbol
RLAY
Transactions as of
Jul 9, 2025
Transactions value $
-$219,123
Form type
4
Date filed
7/10/2025, 04:55 PM
Previous filing
Jul 1, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Patel Sanjiv President and CEO, Director C/O RELAY THERAPEUTICS, INC., 60 HAMPSHIRE STREET, CAMBRIDGE /s/ Brian Adams, as Attorney-in-Fact 2025-07-10 0001816210

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale -$153K -42.7K -5.17% $3.57 784K Jul 9, 2025 Direct F1, F2
transaction RLAY Common Stock Sale -$66.5K -18.6K -2.38% $3.57 765K Jul 9, 2025 Direct F3, F4
holding RLAY Common Stock 200K Jul 9, 2025 By The Patel Family Irrevocable Trust of 2019 F5
holding RLAY Common Stock 687K Jul 9, 2025 By The SSP Irrevocable Trust of 2020 F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 95,295 shares of restricted stock units ("RSUs") on July 8, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F2 Includes 315,265 shares underlying RSUs.
F3 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 41,558 shares of RSUs on July 8, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F4 Includes 273,707 shares underlying RSUs.
F5 These shares are held in irrevocable trusts for the benefit of the reporting person's family members. An independent trustee is trustee of the trusts. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.